Biomedica 2012 - final brochure

The European Life Sciences Summit 2012

Where Science& Business meet

With the support ofOrganised by

The leading interdisciplinary congress in Life

Sciences organised within the Top Technology

Region of Belgium, Germany and The Netherlands

April 18-19, 2012Liège, Belgium • Palais des Congrès

www.biomedicasummit.com

2

April 18-19, 2012 | Liège, Belgium

Biomedica at a glanceHistory

Biomedica started as an initiative of four Life Sciences associations being Bioliège, LifeTechLimburg, LifetecZONe and Lifetec Aachen-Jülich, representing the regions of Liège, Maastricht, Hasselt and Aachen.

Meanwhile Biomedica has grown into a leading conference in Medical Technology and Life Sciences within Belgium, The Netherlands and Germany (North Rhine Westphalia).

Summit figuresBiomedica Summit welcomed participants not only from the Top Technology Region but also from other European countries, USA and Asia.

6th edition 2012 Liège, Belgium 1,200 participants expected !

5th edition 2011 Eindhoven, The Netherlands 1,100 participants

4th edition 2010 Aachen, Germany 950 participants

3rd edition 2009 Liège, Belgium 900 participants

2nd edition 2008 Maastricht, The Netherlands 800 participants

1st edition 2007 Aachen, Germany 460 participants

MÜLLER - FOTTNER - STEINECKE, a team of German and European Patent Attorneys is ranked among the most

recommended intellectual property (IP) law firms in the field of Life Sciences in Germany. Our Office in Jülich is

located in close vicinity to Aachen (Aix-la-chapelle), one of the main population centres of the transnational

Euregio Maas-Rhine. Our second Office is located in Munich, seat of the European Patent Office, the German

Patent and Trademark Office and the German Federal Patent Court. While our firm provides services in all

technical fields, our major areas of expertise are biologics, antibody technology, pharmaceuticals, biosimilars,

diagnostics, food technology and plant biotechnology. In these areas, our firm counsels biotechnology and

pharmaceutical companies as well as Universities and research institutes in obtaining IP rights and defending

against third party rights, e.g. in patent and trademark litigation, nullity proceedings, and opposition appeal

proceedings.

If you would like to arrange an appointment even on short notice, please call or email us. We can either meet you

at the Biomedica or arrange for a meeting at your or our place.

MÜLLER - FOTTNER - STEINECKE

Patent Attorneys Attorneys at Law

Römerstr. 16 b • Postfach / P.O. Box 11 40 • 52412 Jülich • Germany

Tel. +49 (0)2461 341 18-0 • Fax +49 (0)2461 341 18-19 • [email protected]

Locally present - practicing Globally

www.ipbiotech.de

IPB_adv.indd 5 6-2-12 10:26

3The European Life Sciences Summit 2012


Biomedica Summit 2012 When Science & Business meet

Science: find innovative partners from industry & universities

to initiate joined R&D programmes for new products and applications

learn how to build a career in the industry for medical technology & biotechnology

present research results in the poster area

hear the latest breakthroughs obtained by university & industry research

meet experts in one on one meetings during the Matchmaking event

Business: find innovative partners from industry & universities

to initiate joined R&D programmes for new products and applications

find opportunities for out/in licensing your know-how / find a golden business idea

find researchers looking to join your R&D department at the Job fair

hear the latest breakthroughs obtained by university & industry research

meet experts in one on one meetings during the Matchmaking event

Key topics Biopharmaceuticals & nutraceuticals

Session I: Inflammation

Session II: Endocrinology

Medical devices & care Session I: Brain computer interfaces and

neurological disease management

Session II: Image guided neuro interventions

Biomaterials Session I: Biofunctional hydrogels

Session II: Materials for musculoskeletal sport injury repair

Business development & product innovations The Lifetec Life Cycle

Session I: Starting-up a company

Session II: The companies operation

Session III: Company in growth

Session IV: Established company

Biomedica encompasses 50 Business & science presentations

5 Keynotes lectures

100 Poster presentations

5-min’ Pitches

Satellite conferences

2,000 m² Exhibition

A Job fair

A Matchmaking event

Valorisation of IP, Products & Services – VIPS corner

Best poster award

Collaboration award

Cocktail reception & dinner

MÜLLER - FOTTNER - STEINECKE, a team of German and European Patent Attorneys is ranked among the most

recommended intellectual property (IP) law firms in the field of Life Sciences in Germany. Our Office in Jülich is

located in close vicinity to Aachen (Aix-la-chapelle), one of the main population centres of the transnational

Euregio Maas-Rhine. Our second Office is located in Munich, seat of the European Patent Office, the German

Patent and Trademark Office and the German Federal Patent Court. While our firm provides services in all

technical fields, our major areas of expertise are biologics, antibody technology, pharmaceuticals, biosimilars,

diagnostics, food technology and plant biotechnology. In these areas, our firm counsels biotechnology and

pharmaceutical companies as well as Universities and research institutes in obtaining IP rights and defending

against third party rights, e.g. in patent and trademark litigation, nullity proceedings, and opposition appeal

proceedings.

If you would like to arrange an appointment even on short notice, please call or email us. We can either meet you

at the Biomedica or arrange for a meeting at your or our place.

MÜLLER - FOTTNER - STEINECKE

Patent Attorneys Attorneys at Law

Römerstr. 16 b • Postfach / P.O. Box 11 40 • 52412 Jülich • Germany

Tel. +49 (0)2461 341 18-0 • Fax +49 (0)2461 341 18-19 • [email protected]

Locally present - practicing Globally

www.ipbiotech.de

IPB_adv.indd 5 6-2-12 10:26

4


More than a Conference

Poster competition & awardBecome a poster presenter at Biomedica 2012 or find a golden business idea !

(PhD) Students will demonstrate new technologies and research results through a poster presentation

Poster presenters are explicitly asked to link research results to possibilities for commercialization

Submit your poster before March 20th, 2012 Prize: EUR 500 (6 winners)

On April 18th, the Poster Jury will select 12 posters for oral presentations (on April 19th). The awards will be granted during the closing session.

Collaboration awardThis award is launched to promote industry-academia collaborations!

Collaborating companies and academic institutes/universities will be rewarded for innovative application oriented research or projects in the field of life sciences, medical technology or red and white biotechnology

Send your summary before March 20th, 2012 Prize: EUR 10,000 (1 winner)

Four nominees will present their project on April 18th and the winner will be granted on April 19th during the closing session.

5-min PitchesAll Biomedica participants can apply for a pitch:

Present your new technology, patent, product or service

Announce your request for partnerships/cooperation

Ask for financial services or backing

Offer your services

Keynotes Jean-Michel Saive – Table tennis champion,

and supporting patients with cerebral palsy at «Les Coccinelles» (Liège, BE)

Prof. Dr. Sven Olaf Skouby – Session Biopharmaceuticals (University of Esbjerg, DK)

Prof. Dr. Richard Kitney – Session Medical devices (Imperial College, GB)

Prof. Dr. Bert Meijer – Session Biomaterials (Eindhoven University of Technology, NL)

Mr. Robert Dekker – Business Session (Tigenix, BE/NL)

Prof. Dr. Gordana Vunjak-Novakovic – sponsored Session Biomaterials (Columbia University, NY, USA)



More than an ExhibitionMatchmaking eventIn collaboration with Enterprise Europe Network.

Find and meet potential partners and arrange one on one meetings with SME’s from Belgium, Germany and The Netherlands at the Summit.

Access is free and open to all participants of the Summit. However, additional registration is required on www.biomedicasummit.com/specials

Job fairFind your future employer/employee at Biomedica 2012!

Find out how to build a career in the industry.

Unique job opportunities will be presented within the exhibition area by:

companies and R&D institutes

HR representatives

recruiting companies

Access is free and open to all participants of the Summit. Prepare your visit and post your CV on www.vividlinks.eu

VIPS cornerTo stimulate Valorisation of Intellectual properties, Products and Services!

The VIPS corner in Biomedica expo offers Technology Transfer Offices (TTO’s), Liaison offices or Valorisation offices of R&D institutes, Universities and Academic hospitals the opportunity to:

present available patents for licensing and show technology and services to industry representatives

build new relations with the industry and get engaged in cooperative research and development

Do not forget to visit the area!

6


Programme Wednesday 18 April08.30 - 09.30 Registration & Welcome coffee

09.30 - 09.40 Official Opening

09.40 - 09.50 Opening Biomedica by Prof. Dr. Bernard Rentier, Chair of Biomedica Foundation, Recteur, Chair of the board, University of Liège, Belgium

09.50 - 10.20 Keynote PresentationMr. Jean-Michel Saive, Winner European Championship table tennis, one of three table tennis players at all Olympics, Supporter of association «Les Coccinelles», The centre of life for adults with cerebral palsy in LiègeA sport career and patients with cerebral palsy

10.20 - 11.00 Forum discussion - Cerebral palsy: improving living for disabledParticipants:- Mr. Martial Paulus, Director Les Coccinelles, Home centre for adults with cerebral palsy, Liège, Belgium- Prof. Dr. Catherine Disselhorst-Klug, Head of department for rehabilitation & prevention engineering, Helmholz Institute Aachen, Germany- Prof. Dr. Yves Henrotin, Head of bone and cartillage research (U.R.O.C.), University of Liège, Belgium

11.00 - 11.30 Coffee break & Exhibition networking

11.00 - 13.45 MATCHMAKING EVENT

11.30 - 12.30 Biopharmaceuticals & nutraceuticals Session I (Part 1): Inflammation

Medical devices & careSession I (Part 1): Brain computer interfaces and neurological disease management

BiomaterialsSession I (Part 1): Biofunctional hydrogels

The Lifetec Life CycleSession I: Starting-up a company

Chair: Prof. Dr. Sven Hendrix, Department of Anatomy and Cell Biology, Director of the Doctoral School for Medicine & Life Sciences, University of Hasselt, BelgiumCo-chair: Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, Belgium

Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Department, University of Liège, BelgiumCo-chair: to be confirmed

Chair: Prof. Dr. Martin Möller, Director Institute for Technical and Macro-molecular Chemistry, Head of DWI, RWTH Aachen, GermanyCo-chair: Prof. Dr. Christine Jérôme, Centre for Education and Research on Macromolecules, University of Liège, Belgium

Chair: Prof. Dr. Paul Borm, CEO, Nano4technology BV, Geleen, The NetherlandsCo-chair: Mr. Jasper Levink, Consultant, Ttopstart BV, Eindhoven, The Netherlands

11.30 - 11.55 Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, BelgiumActoBiotics - A new class of biopharmaceuticals

11.30 - 11.55 Dr. Quentin Noirhomme, Coma Science Group, Cyclotron Research Centre, University of Liège, BelgiumBrain-computer interface based diagnosis

11.30 - 11.55 Prof. Dr. Jürgen Groll, Department of Functional Materials in Medicine and Dentistry, University of Würzburg, GermanyNanofiber-Hydrogel Composite-Structures for regenerative Medicine

11.30 - 11.50 Dr. Kurt Baeten, CSO MedicaSpec Diagnostics Bvba, Diepenbeek, BelgiumBuilding a start-up: There is far more opportunity than there is ability

11.50 - 12.10 Dr. Frank Bulens, Capricorn Health-tech Fund, Capricorn Venture Partners, Leuven, BelgiumGetting a start-up company financed: some advices

11.55 - 12.20Dr. Mario Losen, Department of Neuroscience, School of Mental Health and Neuroscience, Maastricht University, The NetherlandsImmunotherapy of passive transfer myasthenia gravis in rhesus monkeys

11.55 - 12.20Dr. Silke Musa, Department of Bio- and nanoelectronics, IMEC, Leuven, BelgiumIntegrated microsystems for probing the brain: status and outlook

11.55 - 12.20Prof. Dr. Alan Rowan, Noviotech BV, Nijmegen, The NetherlandsBiomimetic Hydrogel Scaffolds and Extracellular Mimetic Materials - A Question of Stiffness

12.10 - 12.305-min Pitches (4 speakers)

12.30 - 13.45 Lunch break & Exhibition networking | Poster awards jury visits

13.45 - 14.30 Keynote Presentation BIOMATERIALSProf. Dr. Bert Meijer, Institute for Complex Molecular Systems, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology, The NetherlandsSupramolecular biomaterials; a modular approach to functional systems




The Lifetec Life CycleSession II: The companies operation


Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Dept, University of Liège, BelgiumCo-chair: to be confirmed


Chair: Mr. Peter Meijlink, Forte BV, The NetherlandsCo-chair: Dr. Paulette Wauben, Senior Project Manager, NV Industriebank LIOF, Maastricht, The Netherlands

14.30 - 15.00Prof. Dr. Dirk Elewaut, Division of Rheumatology, University of Ghent, BelgiumNew insights in to the underlying mechanisms of inflammation in spondyloarthritis: a prototypic immune mediated inflammatory disorder

14.30 - 15.00Dr. Christoph Guger, CEO, Gtec medical engineering GmbH, Schiedlberg, AustriaNon-invasive and invasive BCI system application

14.30 - 15.00Prof. Dr. Doris Klee, ITMC, RWTH Aachen University, GermanyStarshaped Polymeric Hydrogels for Biomedical Applications

14.30 - 14.50Dr. Ir. Erwin Blomsma, CEO, Okapi Sciences NV, Leuven, BelgiumOkapi Sciences: beyond the start, before the exit

14.50 - 15.10Mr. Ludovic Dornier, International Business Development, LC2, Lentilly, FranceCustomization: Key to successful co-operation

15.00 - 15.30Dr. Martin Sims, Research Director Apitope International NV, Hasselt, Belgium.Apitopes: improving treatment of autoimmune and allergic conditions through rational design of peptide epitopes

15.00 - 15.30Dr. Febo Cincotti, Department of Clinical Neurophysiology, Neuroelectrical Imaging and BCI Lab, Santa Lucia Fondation, IRCCS, Rome, ItalyTranslational Issues for BCI in Neurorehabilitation

15.00 - 15.30Dr. Ir. Aart Molenberg, Director, Head of Biomaterials & Surfaces Research, Straumann AG, Basel, SwitzerlandDevelopment of a Hydrogel Medical Device: Straumann® MembraGel



16.00 - 16.40 Keynote Presentation BIOPHARMACEUTICALSProf. Dr. Sven Olaf Skouby, Director of Endocrinological and Reproductive Unit - Department Obstetrics and Gynecology Herlev Hospital, Faculty of Health Sciences, University of Copenhagen and Department of Thrombosis Research, University of Esbjerg, DenmarkThe Safety of Oral Contraception: new challenges




Collaboration Award session




Chair: Mrs Ria Hein, Brabantse Ontwikkelingsmaatschappij (BOM), Biomedica Board Member, The Netherlands

16.45 - 17.15Prof. Dr. Orhan Aktas, Molecular Neurology Research Group, Heinrich-Heine University Hospital, Düsseldorf, GermanyEvolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria

16.45 - 17.15Prof. Dr. Robert Poirrier, Centre for Sleep Disorders, CHU, University of Liège, BelgiumSleep disorders and today technologies

16.45 - 17.15Dr. Dimitriya Bozukova, Project Leader Research & Development, QC Advisor, PhysIOL NV, Liège, BelgiumSurface and bulk properties of hydrogels for intraocular lenses

Nominee Award session

Chair: Mrs Ria Hein- Introduction: Mrs Ria Hein- Nominee 1: 17.00 -17.15- Nominee 2: 17.15 -17.30- Nominee 3: 17.30 -17.45- Nominee 4: 17.45 - 18.00

17.15 - 17.45Prof. Dr. Cornelis Kluft, Head of research, Good Biomarker Sciences, Leiden, The NetherlandsSafety pharmacodynamics methods to assess inflammation and coagulation

17.15 - 17.45Dr. Roy Raymann, Senior Scientist in Sleep, Secretary at Dutch Sleep Wake Society, Philips Research, Eindhoven, The NetherlandsSupporting Sleep; Non-pharmacological interventions originating from neuro- and behavioral sciences

17.15 - 17.45Prof. Dr. Jennifer Patterson, Department of Metallurgy and Materials Engineering, KU Leuven, BelgiumBiofunctionalization of Molecularly Engineered Hydrogels for an Enhanced Cellular Response

18.00 - 21.30 Transfer and Cocktail Reception & Dinner



08.30 - 09.30 Registration & Welcome coffee

09.30 - 09.40 Official Opening

09.40 - 09.50 Opening Biomedica by Prof. Dr. Bernard Rentier, Chair of Biomedica Foundation, Recteur, Chair of the board, University of Liège, Belgium

09.50 - 10.20 Keynote PresentationMr. Jean-Michel Saive, Winner European Championship table tennis, one of three table tennis players at all Olympics, Supporter of association «Les Coccinelles», The centre of life for adults with cerebral palsy in LiègeA sport career and patients with cerebral palsy

10.20 - 11.00 Forum discussion - Cerebral palsy: improving living for disabledParticipants:- Mr. Martial Paulus, Director Les Coccinelles, Home centre for adults with cerebral palsy, Liège, Belgium- Prof. Dr. Catherine Disselhorst-Klug, Head of department for rehabilitation & prevention engineering, Helmholz Institute Aachen, Germany- Prof. Dr. Yves Henrotin, Head of bone and cartillage research (U.R.O.C.), University of Liège, Belgium






The Lifetec Life CycleSession I: Starting-up a company


Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Department, University of Liège, BelgiumCo-chair: to be confirmed


Chair: Prof. Dr. Paul Borm, CEO, Nano4technology BV, Geleen, The NetherlandsCo-chair: Mr. Jasper Levink, Consultant, Ttopstart BV, Eindhoven, The Netherlands

11.30 - 11.55 Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, BelgiumActoBiotics - A new class of biopharmaceuticals

11.30 - 11.55 Dr. Quentin Noirhomme, Coma Science Group, Cyclotron Research Centre, University of Liège, BelgiumBrain-computer interface based diagnosis

11.30 - 11.55 Prof. Dr. Jürgen Groll, Department of Functional Materials in Medicine and Dentistry, University of Würzburg, GermanyNanofiber-Hydrogel Composite-Structures for regenerative Medicine

11.30 - 11.50 Dr. Kurt Baeten, CSO MedicaSpec Diagnostics Bvba, Diepenbeek, BelgiumBuilding a start-up: There is far more opportunity than there is ability

11.50 - 12.10 Dr. Frank Bulens, Capricorn Health-tech Fund, Capricorn Venture Partners, Leuven, BelgiumGetting a start-up company financed: some advices

11.55 - 12.20Dr. Mario Losen, Department of Neuroscience, School of Mental Health and Neuroscience, Maastricht University, The NetherlandsImmunotherapy of passive transfer myasthenia gravis in rhesus monkeys

11.55 - 12.20Dr. Silke Musa, Department of Bio- and nanoelectronics, IMEC, Leuven, BelgiumIntegrated microsystems for probing the brain: status and outlook

11.55 - 12.20Prof. Dr. Alan Rowan, Noviotech BV, Nijmegen, The NetherlandsBiomimetic Hydrogel Scaffolds and Extracellular Mimetic Materials - A Question of Stiffness


12.30 - 13.45 Lunch break & Exhibition networking | Poster awards jury visits

13.45 - 14.30 Keynote Presentation BIOMATERIALSProf. Dr. Bert Meijer, Institute for Complex Molecular Systems, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology, The NetherlandsSupramolecular biomaterials; a modular approach to functional systems




The Lifetec Life CycleSession II: The companies operation




Chair: Mr. Peter Meijlink, Forte BV, The NetherlandsCo-chair: Dr. Paulette Wauben, Senior Project Manager, NV Industriebank LIOF, Maastricht, The Netherlands

14.30 - 15.00Prof. Dr. Dirk Elewaut, Division of Rheumatology, University of Ghent, BelgiumNew insights in to the underlying mechanisms of inflammation in spondyloarthritis: a prototypic immune mediated inflammatory disorder

14.30 - 15.00Dr. Christoph Guger, CEO, Gtec medical engineering GmbH, Schiedlberg, AustriaNon-invasive and invasive BCI system application

14.30 - 15.00Prof. Dr. Doris Klee, ITMC, RWTH Aachen University, GermanyStarshaped Polymeric Hydrogels for Biomedical Applications

14.30 - 14.50Dr. Ir. Erwin Blomsma, CEO, Okapi Sciences NV, Leuven, BelgiumOkapi Sciences: beyond the start, before the exit

14.50 - 15.10Mr. Ludovic Dornier, International Business Development, LC2, Lentilly, FranceCustomization: Key to successful co-operation

15.00 - 15.30Dr. Martin Sims, Research Director Apitope International NV, Hasselt, Belgium.Apitopes: improving treatment of autoimmune and allergic conditions through rational design of peptide epitopes

15.00 - 15.30Dr. Febo Cincotti, Department of Clinical Neurophysiology, Neuroelectrical Imaging and BCI Lab, Santa Lucia Fondation, IRCCS, Rome, ItalyTranslational Issues for BCI in Neurorehabilitation

15.00 - 15.30Dr. Ir. Aart Molenberg, Director, Head of Biomaterials & Surfaces Research, Straumann AG, Basel, SwitzerlandDevelopment of a Hydrogel Medical Device: Straumann® MembraGel



16.00 - 16.40 Keynote Presentation BIOPHARMACEUTICALSProf. Dr. Sven Olaf Skouby, Director of Endocrinological and Reproductive Unit - Department Obstetrics and Gynecology Herlev Hospital, Faculty of Health Sciences, University of Copenhagen and Department of Thrombosis Research, University of Esbjerg, DenmarkThe Safety of Oral Contraception: new challenges




Collaboration Award session




Chair: Mrs Ria Hein, Brabantse Ontwikkelingsmaatschappij (BOM), Biomedica Board Member, The Netherlands

16.45 - 17.15Prof. Dr. Orhan Aktas, Molecular Neurology Research Group, Heinrich-Heine University Hospital, Düsseldorf, GermanyEvolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria

16.45 - 17.15Prof. Dr. Robert Poirrier, Centre for Sleep Disorders, CHU, University of Liège, BelgiumSleep disorders and today technologies

16.45 - 17.15Dr. Dimitriya Bozukova, Project Leader Research & Development, QC Advisor, PhysIOL NV, Liège, BelgiumSurface and bulk properties of hydrogels for intraocular lenses

Nominee Award session

Chair: Mrs Ria Hein- Introduction: Mrs Ria Hein- Nominee 1: 17.00 -17.15- Nominee 2: 17.15 -17.30- Nominee 3: 17.30 -17.45- Nominee 4: 17.45 - 18.00

17.15 - 17.45Prof. Dr. Cornelis Kluft, Head of research, Good Biomarker Sciences, Leiden, The NetherlandsSafety pharmacodynamics methods to assess inflammation and coagulation

17.15 - 17.45Dr. Roy Raymann, Senior Scientist in Sleep, Secretary at Dutch Sleep Wake Society, Philips Research, Eindhoven, The NetherlandsSupporting Sleep; Non-pharmacological interventions originating from neuro- and behavioral sciences

17.15 - 17.45Prof. Dr. Jennifer Patterson, Department of Metallurgy and Materials Engineering, KU Leuven, BelgiumBiofunctionalization of Molecularly Engineered Hydrogels for an Enhanced Cellular Response

18.00 - 21.30 Transfer and Cocktail Reception & Dinner

8


Programme Thursday 19 April08.30 - 09.30 Registration & Welcome coffee

09.30 - 10.10 Keynote Presentation MEDICAL DEVICESProf. Dr. Richard Kitney, Imperial College, London, GBTitle to be confirmed

11.15 - 11.15 Biopharmaceuticals & nutraceuticals Session II (Part 1): Endocrinology

Medical devices & careSession II (Part 1): Image guided neuro interventions

BiomaterialsSession II (Part 1): Materials for musculoskeletal sport injury repair

The Lifetec Life Cycle Session III: Company in growth

Satellite conference 1(10.15 - 11.15)

Chair: Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The NetherlandsCo-chair: Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, Belgium

Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Prof. Dr. Richard Kitney, Imperial College, London, GB

Chair: Prof. Dr. Yves Henrotin, Head of Bone and Cartillage research (U.R.O.C.), University of Liège, BelgiumCo-chair: Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, France

Chair: Dr. Bernward Garthoff, Clustermanager BIO.NRW, Düsseldorf, GermanyCo-chair: Ir. John Paes, Chairman of Board of Commissioners, Technomed Europe, Maastricht-Airport, The Netherlands

10.15 - 10.40Prof. Dr. Albert Beckers, Chief Department of Endocrinology, CHU, University of Liège, BelgiumThe problems of orphan diseases: the example of FIPA (familial isolated pituitary adenoma), an orphan disease with well documented genetic aberrations but without therapeutic insights. New perspectives?

10.15 - 10.40Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, GermanyHybrid MR-PET Imaging at 9.4T: Challenges and Opportunities

10.15 - 10.40Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, FranceStem cells and cartillage repair: myth or reality

10.15 - 10.35Dr. Vincent Larik, Managing Director, Applied Biomedical Systems, Maastricht, The NetherlandsApproach to the market

10.40 - 11.05Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, BelgiumThe development of an intra-uterine device releasing controlled amounts of Levonorgestrel

10.40 - 11.05Prof. Dr. Philippe A. Coucke, Department of Clinical Sciences, Radiotherapy, University of Liège, BelgiumRobotic stereotactic radiosurgery and stereotactic body radiotherapy: How technical improvement does significantly influence outcome

10.40 - 11.05Dr. Véronique Maquet, Kitozyme SA, BelgiumAdvances in biomaterials to repair cartilage

10.35 - 10.55Dr. Alexander Vos, Pharmacell BV, Maastricht, The NetherlandsHow to organize cooperation between companies world wide

11.05 - 11.15Poster presentations (2)









The Lifetec Life Cycle Session IV (Part 1): Established company



Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Germany


Chair: Dr. Oliver Lehmkühler, Clustermanager MedizinTechnik NRW, Düsseldorf, GermanyCo-chair: Dr. Ute Schelhaas, Agit GmbH, Aachen, Germany

11.45 - 12.15Prof. Dr. Jean-Michel Foidart, Head of Obstetric & Gynecologycal Department, CHU, ULg, Founder and CSO Uteron Pharma, Mythra, Liège, BelgiumEstetrol : A recently described fetal estrogen with unique properties: development of contraceptive applications

11.45 - 12.15Dr. Hubert Martens, Co-founder, Director of Clinical Sciences and Applications, Sapiens Steering Brain Stimulation BV, Eindhoven, The NetherlandsNext generation electrodes for steering brain stimulation

11.45 - 12.15Speaker and title to be confirmed

11.45 - 12.05Dr. rer. pol. Michael Gebauer, CEO, CorTAG Molecular Diagnostics GmbH, Dortmund, GermanyStrategy and future: Cardiogenetic Diagnostics

12.15 - 12.45Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The NetherlandsEstetrol use in postmenopausal women, protection of the breast

12.15 - 12.45Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, BelgiumFunctional imaging guided electrode implantation for tinnitu

12.15 - 12.45Prof. Dr. Daniel Saris, Co-director Biological Joint Reconstruction Research, President of the International cartilage repair society, University of Utrecht, The NetherlandsClinical evidence of cartilage repair efficacy

12.10 - 12.30Mr. Robert Dekker, Manager IP & Business development, Tigenix, Leuven/Geleen, Belgium/The NetherlandsTiGenix, from idea to European leader in cell therapy




12.35 - 12.55Dr. Bob Kool, CEO, Basic Pharma BV, Geleen, The NetherlandsChallenges in a growing company

13.00 - 14.00 Lunch break & Exhibition networking







Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, Belgium



14.00 - 14.25Prof. Dr. Andrea Genazzani, Director of the Department Obstetrics and Gynecology, President of the International Society of Gynecological Endocrinology, and of the European Society for Gynecologic and Obstetric Investigation, University of Pisa, ItalyIndependent Academic Investigations and Industrial constraints: an easy interaction?

14.00 - 14.25Prof. Dr. Yasin Temel, Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, The NetherlandsFinding the right spot for deep brain stimulation in Parkinson’s disease

14.00 - 14.25Prof. Dr. Liesbet Geris, Department of Aerospace and Mechanics, University of Liège, BelgiumFrom mechanisms to therapy via mathematical models in fracture healing

14.00 - 14.15Dr. Tolleiv Trimborn, CEO, Arcarios, Rotterdam, The NetherlandsRealizing your exit

14.15 - 14.30Ir. Kees van Gorsel, AIM, Brunssum, The NetherlandsChallenges between prototype and market introduction

14.30 - 14.45Dr. Peter Brands, Research coordinator, Esaote Europe BV, Maastricht, The NetherlandsCooperation with academia: Innovations in Ultrasound imaging

14.25 - 14.50Dr. Nathalie Ledée, Head of research INSERM, Hopital St. Louis, Paris 7, FranceFollicular fluid G-CSF, a new noninvasive tool, for human embryo selection

14.25 - 14.50Prof. Dr. Bart ter Haar Romeny, Biomedical Image Analysis (BMIA), Department of Biomedical Engineering, Eindhoven University of Technology, The NetherlandsVisualization of structural and functional brain connectivity for neurosurgical applications

14.25 - 14.50Prof. Dr. Madry Henning, Chair of Experimental Orthopaedics and Osteoarthritis Research, Saarland University Medical Center, Homburg/Saar, GermanyAdvances in techniques for meniscus repair


15.15 - 16.15 5-min Pitches in Plenary (12 speakers)

16.15 - 17.00 Keynote Presentation BIOMATERIALS (sponsored by Biomimedics)Prof. Dr. Gordana Vunjak-Novakovic, Mikati Foundation Professor of Biomedical Engineering, Vice-Chair & Professor of Biomedical Engineering and Medical Sciences (in Medicine), Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University, NY, USA

Cell-instructive biomaterials for tissue engineering and regenerative medicine

17.00 - 17.30 Collaboration award ceremony, poster awards & closing session



08.30 - 09.30 Registration & Welcome coffee

09.30 - 10.10 Keynote Presentation MEDICAL DEVICESProf. Dr. Richard Kitney, Imperial College, London, GBTitle to be confirmed




The Lifetec Life Cycle Session III: Company in growth



Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Prof. Dr. Richard Kitney, Imperial College, London, GB


Chair: Dr. Bernward Garthoff, Clustermanager BIO.NRW, Düsseldorf, GermanyCo-chair: Ir. John Paes, Chairman of Board of Commissioners, Technomed Europe, Maastricht-Airport, The Netherlands

10.15 - 10.40Prof. Dr. Albert Beckers, Chief Department of Endocrinology, CHU, University of Liège, BelgiumThe problems of orphan diseases: the example of FIPA (familial isolated pituitary adenoma), an orphan disease with well documented genetic aberrations but without therapeutic insights. New perspectives?

10.15 - 10.40Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, GermanyHybrid MR-PET Imaging at 9.4T: Challenges and Opportunities

10.15 - 10.40Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, FranceStem cells and cartillage repair: myth or reality

10.15 - 10.35Dr. Vincent Larik, Managing Director, Applied Biomedical Systems, Maastricht, The NetherlandsApproach to the market

10.40 - 11.05Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, BelgiumThe development of an intra-uterine device releasing controlled amounts of Levonorgestrel

10.40 - 11.05Prof. Dr. Philippe A. Coucke, Department of Clinical Sciences, Radiotherapy, University of Liège, BelgiumRobotic stereotactic radiosurgery and stereotactic body radiotherapy: How technical improvement does significantly influence outcome

10.40 - 11.05Dr. Véronique Maquet, Kitozyme SA, BelgiumAdvances in biomaterials to repair cartilage

10.35 - 10.55Dr. Alexander Vos, Pharmacell BV, Maastricht, The NetherlandsHow to organize cooperation between companies world wide













Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Germany



11.45 - 12.15Prof. Dr. Jean-Michel Foidart, Head of Obstetric & Gynecologycal Department, CHU, ULg, Founder and CSO Uteron Pharma, Mythra, Liège, BelgiumEstetrol : A recently described fetal estrogen with unique properties: development of contraceptive applications

11.45 - 12.15Dr. Hubert Martens, Co-founder, Director of Clinical Sciences and Applications, Sapiens Steering Brain Stimulation BV, Eindhoven, The NetherlandsNext generation electrodes for steering brain stimulation

11.45 - 12.15Speaker and title to be confirmed

11.45 - 12.05Dr. rer. pol. Michael Gebauer, CEO, CorTAG Molecular Diagnostics GmbH, Dortmund, GermanyStrategy and future: Cardiogenetic Diagnostics

12.15 - 12.45Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The NetherlandsEstetrol use in postmenopausal women, protection of the breast

12.15 - 12.45Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, BelgiumFunctional imaging guided electrode implantation for tinnitu

12.15 - 12.45Prof. Dr. Daniel Saris, Co-director Biological Joint Reconstruction Research, President of the International cartilage repair society, University of Utrecht, The NetherlandsClinical evidence of cartilage repair efficacy

12.10 - 12.30Mr. Robert Dekker, Manager IP & Business development, Tigenix, Leuven/Geleen, Belgium/The NetherlandsTiGenix, from idea to European leader in cell therapy




12.35 - 12.55Dr. Bob Kool, CEO, Basic Pharma BV, Geleen, The NetherlandsChallenges in a growing company

13.00 - 14.00 Lunch break & Exhibition networking







Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The NetherlandsCo-chair: Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, Belgium



14.00 - 14.25Prof. Dr. Andrea Genazzani, Director of the Department Obstetrics and Gynecology, President of the International Society of Gynecological Endocrinology, and of the European Society for Gynecologic and Obstetric Investigation, University of Pisa, ItalyIndependent Academic Investigations and Industrial constraints: an easy interaction?

14.00 - 14.25Prof. Dr. Yasin Temel, Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, The NetherlandsFinding the right spot for deep brain stimulation in Parkinson’s disease

14.00 - 14.25Prof. Dr. Liesbet Geris, Department of Aerospace and Mechanics, University of Liège, BelgiumFrom mechanisms to therapy via mathematical models in fracture healing

14.00 - 14.15Dr. Tolleiv Trimborn, CEO, Arcarios, Rotterdam, The NetherlandsRealizing your exit

14.15 - 14.30Ir. Kees van Gorsel, AIM, Brunssum, The NetherlandsChallenges between prototype and market introduction

14.30 - 14.45Dr. Peter Brands, Research coordinator, Esaote Europe BV, Maastricht, The NetherlandsCooperation with academia: Innovations in Ultrasound imaging

14.25 - 14.50Dr. Nathalie Ledée, Head of research INSERM, Hopital St. Louis, Paris 7, FranceFollicular fluid G-CSF, a new noninvasive tool, for human embryo selection

14.25 - 14.50Prof. Dr. Bart ter Haar Romeny, Biomedical Image Analysis (BMIA), Department of Biomedical Engineering, Eindhoven University of Technology, The NetherlandsVisualization of structural and functional brain connectivity for neurosurgical applications

14.25 - 14.50Prof. Dr. Madry Henning, Chair of Experimental Orthopaedics and Osteoarthritis Research, Saarland University Medical Center, Homburg/Saar, GermanyAdvances in techniques for meniscus repair


15.15 - 16.15 5-min Pitches in Plenary (12 speakers)

16.15 - 17.00 Keynote Presentation BIOMATERIALS (sponsored by Biomimedics)Prof. Dr. Gordana Vunjak-Novakovic, Mikati Foundation Professor of Biomedical Engineering, Vice-Chair & Professor of Biomedical Engineering and Medical Sciences (in Medicine), Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University, NY, USA

Cell-instructive biomaterials for tissue engineering and regenerative medicine

17.00 - 17.30 Collaboration award ceremony, poster awards & closing session

10


Confirmed sponsors & exhibitors 2012Organised by

Supporting universities

Diamond sponsors

Gold sponsors

Silver sponsors

Additional sponsors and exhibitors

Matchmaking event partner Job fair partners

With the support of

Woman health, our future !



Word from Mr. Mestrez, Deputy Province of Liège

Biomedica – A Brainchild of EuregioVarious Interreg projects from the Euregio Meuse-Rhine, like “Life Science” or “In Europa”, brought Life Science key players in the Euregio together and formed the basis for successful cooperation.

By joining forces, tools and know-how and by integrating the potential of Leuven and Eindhoven, they created the “Top Technology Region” which has become a Life Science forefront in Europe and worldwide. Biomedica results from a fusion of several similar events in this region. Each year, it receives a financial support from the Euregio partner regions.

So, we are proud to welcome the Event in Liège again, in 2012.

It is an undeniable fact that our active companies in the domain of Biotechnology, mostly of University of Liège’s spin-offs, are augur well for the future development of the region.

Let us give some examples of their important implication in the regional business structure:

Jean-Pierre Delwart, the head of Eurogentec, was Chairman of the Walloon Business Union “Union Wallonne des Entreprises” for 3 years, and François Fornieri, Founder and administrator of Mithra Pharmaceuticals, a University of Liège spin off, has just won the title of Belgian Manager of the Year. Beside these flagships, there are so many other innovative and creative biotechnical companies.

Let’s mention the “GIGA”, an interdisciplinary cluster for applied genoproteomics, whose concept has stirred up the international interest. It is a major pole of research and development for activities in the biotech area, promoting communication and interaction among various departments and faculties, as well as enhancing and relying on a close collaboration between research and business. Only a few similar centers in Europe have come so far in incorporating academic research, collaborations with companies and technology transfer centers.

It’s impossible to ignore the “Liège Science Park”, under the responsibility of the Company-University Interface of the ULg, which is one of the partner organizers of Biomedica 2012. Several innovative companies are located in this business park, most of those spin-offs from ULg, have a close link to university research.

Liège is very proud of its assets, and would like to welcome all participants. We invite them to participate and enjoy the city life, feel its quality of life and sense of hospitality. We hope they will return for the upcoming major events, like the Start of the Tour de France in June 2012, the Euroskills in October 2012 and, especially the International Exhibition in 2017.

Have a nice stay and a good conference.

Julien MestrezDeputy, Province of Liège

Steering Committee member Euregio Meuse-Rhine

The European Life Sciences Summit 2012

Practical informationRegistrationRegister now on www.biomedicasummit.com

HotelsHotels have been selected for the event. You can book hotel accommodation when registering online. Availability and rates guaranteed until February 29.

Evening dinner April 18You can improve your network at Biomedica by attending the evening diner within the centre of Liège.

The Biomedica evening dinner will be served at the Ballroom of the 5 ***** Crowne Plaza Liège, Les Comtes de Mean.

This mansion originated from the 15th century, has been reconstructed into its original state and offers a Napoleon like atmosphere. From here you will have a breathtaking view on the city of Liège.

VenuePalais des Congrès de Liège

Esplanade de l’Europe, 2

4020 Liège – Belgium

All information on « how to get there » on www.biomedicasummit.com/info

Business delegate – 2 days EUR 235 (excl. 21% VAT)

Business delegate – 1 day EUR 175 (excl. 21% VAT)

Researcher / University delegate (2 days) EUR 150 (excl. 21% VAT)

Student (2 days) EUR 45 (excl. 21% VAT)

35

38

> A602BruxellesNamur

> E25Ardennes

> E25Maastricht

VersE25

Pont deHuy

Pont duRoi Albert I

Pont Atlas V

Hallesdes Foires

Parcd’Avroy

GareTGV

Bd Raymond-Poincaré

PalaisdesCongrès

La Dériv

ation

La Meuse

Sponsors & ExhibitorsInterested in participating as a Sponsor or Exhibitor?

Contact Mandy Rizzo [email protected]

Contact us For any questions or information contact

Mindstream (Professional Congress Organiser)

Av. Vésale 8c – 1300 Wavre – Belgium

T : +32(0)10 22 40 83 – F : +32(0)10 24 70 48

[email protected]


This announcement has been printed with the support of

Date post:	12-Mar-2016
Category:	Documents
Upload:	michiel-stoffels
View:	222 times
Download:	7 times

Biomedica 2012 - final brochure

Documents